The remodeling process in bone yields numerous cytokines and chemokines that mediate crosstalk between osteoblasts and osteoclasts and also serve to attract and support metastatic tumor cells. The metastatic tumor cells disturb the equilibrium in bone that manifests as skeletal complications. The Hedgehog (Hh) pathway plays an important role in skeletogenesis. We hypothesized that the Hh pathway mediates an interaction between tumor cells and osteoblasts and influences osteoblast differentiation in response to tumor cells. We have determined that breast tumor cells have an activated Hh pathway characterized by upregulation of the ligand, IHH and transcription factor GLI1. Breast cancer cells interact with osteoblasts and cause an enhanced differentiation of pre-osteoblasts to osteoblasts that express increased levels of the osteoclastogenesis factors, RANKL and PTHrP. There is sustained expression of osteoclast-promoting factors, RANKL and PTHrP, even after the osteoblast differentiation ceases and apoptosis sets in. Moreover, tumor cells that are deficient in Hh signaling are compromised in their ability to induce osteoblast differentiation and consequently are inefficient in causing osteolysis. The stimulation of osteoblast differentiation sets the stage for osteoclast differentiation and overall promotes osteolysis. Thus, in the process of developing newer therapeutic strategies against breast cancer metastasis to bone it would worthwhile to keep in mind the role of the Hh pathway in osteoblast differentiation in an otherwise predominant osteolytic phenomenon.
References
[1]
Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584–593.
[2]
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537–549.
[3]
Jemtland R, Divieti P, Lee K, Segre GV (2003) Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone 32: 611–620.
[4]
Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, et al. (2006) The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res 66: 7548–7553.
[5]
Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, et al. (2007) Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18: 2411–2418.
[6]
Ehlen HW, Buelens LA, Vortkamp A (2006) Hedgehog signaling in skeletal development. Birth Defects Res C Embryo Today 78: 267–279.
[7]
Das S, Samant RS, Shevde LA (2010) Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem.
[8]
Das S, Harris LG, Metge BJ, Liu S, Riker AI, et al. (2009) The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 284: 22888–22897.
[9]
Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, et al. (2006) Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435. Clin Exp Metastasis 23: 123–133.
[10]
Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, et al. (2004) A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis 21: 119–128.
[11]
Mastro AM, Gay CV, Welch DR, Donahue HJ, Jewell J, et al. (2004) Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation. J Cell Biochem 91: 265–276.
[12]
Nefussi JR, Brami G, Modrowski D, Oboeuf M, Forest N (1997) Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro. J Histochem Cytochem 45: 493–503.
[13]
Collin P, Nefussi JR, Wetterwald A, Nicolas V, Boy-Lefevre ML, et al. (1992) Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcif Tissue Int 50: 175–183.
[14]
Carvalho RS, Kostenuik PJ, Salih E, Bumann A, Gerstenfeld LC (2003) Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression. Matrix Biol 22: 241–249.
[15]
Carvalho RS, Schaffer JL, Gerstenfeld LC (1998) Osteoblasts induce osteopontin expression in response to attachment on fibronectin: demonstration of a common role for integrin receptors in the signal transduction processes of cell attachment and mechanical stimulation. J Cell Biochem 70: 376–390.
[16]
Liu YK, Uemura T, Nemoto A, Yabe T, Fujii N, et al. (1997) Osteopontin involvement in integrin-mediated cell signaling and regulation of expression of alkaline phosphatase during early differentiation of UMR cells. FEBS Lett 420: 112–116.
[17]
Maun HR, Wen X, Lingel A, de Sauvage FJ, Lazarus RA, et al. (2010) Hedgehog pathway antagonist 5E1 binds hedgehog at the pseudo-active site. J Biol Chem 285: 26570–26580.
[18]
Chen YC, Sosnoski DM, Mastro AM (2010) Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 12: 215.
[19]
Martin TJ (2005) Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115: 2322–2324.
[20]
McKee MD, Nanci A (1996) Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35: 197–205.
[21]
Nakamura T, Aikawa T, Iwamoto-Enomoto M, Iwamoto M, Higuchi Y, et al. (1997) Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun 237: 465–469.
[22]
Enomoto-Iwamoto M, Nakamura T, Aikawa T, Higuchi Y, Yuasa T, et al. (2000) Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation. J Bone Miner Res 15: 1659–1668.
[23]
Kesper DA, Didt-Koziel L, Vortkamp A (2010) Gli2 activator function in preosteoblasts is sufficient to mediate Ihh-dependent osteoblast differentiation, whereas the repressor function of Gli2 is dispensable for endochondral ossification. Dev Dyn 239: 1818–1826.
[24]
Kiuru M, Solomon J, Ghali B, van der Meulen M, Crystal RG, et al. (2009) Transient overexpression of sonic hedgehog alters the architecture and mechanical properties of trabecular bone. J Bone Miner Res 24: 1598–1607.
[25]
Mercer RR, Miyasaka C, Mastro AM (2004) Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clin Exp Metastasis 21: 427–435.
[26]
Mercer RR, Mastro AM (2005) Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K. Exp Cell Res 310: 270–281.
[27]
Bussard KM, Gay CV, Mastro AM (2008) The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev 27: 41–55.
[28]
Helming L, Gordon S (2009) Molecular mediators of macrophage fusion. Trends Cell Biol 19: 514–522.
[29]
Singh S, Wang Z, Liang Fei D, Black KE, Goetz JA, et al. (2011) Hedgehog-Producing Cancer Cells Respond to and Require Autocrine Hedgehog Activity. Cancer Res 71: 4454–4463.
[30]
O'Toole SA, Machalek DA, Shearer RF, Millar EK, Nair R, et al. (2011) Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res 71: 4002–4014.
[31]
Xuan Y, Lin Z (2009) Expression of Indian Hedgehog signaling molecules in breast cancer. J Cancer Res Clin Oncol 135: 235–240.
[32]
Souzaki M, Kubo M, Kai M, Kameda C, Tanaka H, et al. (2011) Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci 102: 373–381.
[33]
Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, et al. (2004) Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 64: 6071–6074.
[34]
Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, et al. (2009) The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res 29: 871–879.
[35]
Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, et al. (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34. J Clin Invest 115: 2402–2411.
[36]
Miao D, Li J, Xue Y, Su H, Karaplis AC, et al. (2004) Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145: 3554–3562.
[37]
Kasper M, Jaks V, Fiaschi M, Toftgard R (2009) Hedgehog signalling in breast cancer. Carcinogenesis 30: 903–911.
[38]
Katano M (2005) Hedgehog signaling pathway as a therapeutic target in breast cancer. Cancer Lett 227: 99–104.
[39]
Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, et al. (2006) Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 5: 674–683.
[40]
Casimiro S, Guise TA, Chirgwin J (2009) The critical role of the bone microenvironment in cancer metastases. Mol Cell Endocrinol 310: 71–81.
